Physician
Vascular Surgery
Dr. John D. Horowitz, MD
|
|
Give Review
Doctor John D. Horowitz, MD works in the field of Vascular Surgery. He attended Temple University School of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". John Horowitz is a published doctor and has 101 publications published. The lastest was: 'Nitrate therapy is an alternative to furosemide/morphine therapy in the management of acute cardiogenic pulmonary edema.'
Publications
- Pathogenesis of Aortic sclerosis: association with low BMI, tissue nitric oxide resistance, but not systemic inflammatory activation.
- Tachycardic vs. pharmacologic stress myocardial perfusion imaging: differential implications in multi-vessel ischemia.
- Navigating the fine line between benefit and risk in Chronic atrial fibrillation: Rationale and design of the Standard versus Atrial Fibrillation spEcific managemenT s...
- Warfarin and acetaminophen interaction: a summary of the evidence and biological plausibility.
- N-Terminal Pro-Brain Natriuretic Protein Levels in Takotsubo Cardiomyopathy.
- Effects of aging, Renal dysfunction, left ventricular systolic impairment, and weight on steady state pharmacokinetics of perhexiline.
- Clinical Trials Update AHA Congress 2010.
- Pathogenesis of Aortic stenosis: not just a matter of wear and tear.
- Perhexiline and hypertrophic cardiomyopathy: a new horizon for metabolic modulation.
- Modulation of myocardial metabolism: an emerging therapeutic principle.
- Hydralazine does not ameliorate nitric oxide resistance in Chronic heart failure.
- Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations?
- Lack of association between Aortic sclerosis and left ventricular hypertrophy in elderly subjects.
- Determinants of occurrence of Aortic sclerosis in an aging population.
- Management of the metabolic syndrome in cardiovascular Disease.
- Carotid angioplasty and stenting is a safe and durable procedure in a community hospital.
- Effect of CYP2D6 metabolizer status on the disposition of the (+) and (-) enantiomers of perhexiline in patients with myocardial ischaemia.
- Aortic stenosis is associated with elevated plasma levels of asymmetric dimethylarginine (ADMA).
- The deleterious effects of hyperglycemia on platelet function in diabetic patients with Acute coronary syndromes mediation by superoxide production, resolution with in...
- Perhexiline.
- Extending the horizon in Chronic heart failure: effects of multidisciplinary, home-based intervention relative to usual care.
- Time to address the cardiac metabolic "triple whammy" Ischemic heart failure in diabetic patients.
- Attenuation of the negative inotropic effects of metoprolol at short cycle lengths in humans: comparison with sotalol and verapamil.
- Suspected DLIS interference in the dimension DGNA digoxin assay method and the clinical application of the revised digoxin target range.
- Platelet nitric oxide responsiveness: a novel prognostic marker in Acute coronary syndromes.
- Dissociation between metabolic and efficiency effects of perhexiline in normoxic rat myocardium.
- Angiotensin-(1-7) enhances anti-aggregatory effects of the nitric oxide donor sodium nitroprusside.
- Once-monthly administration of darbepoetin alfa for the treatment of patients with Chronic heart failure and anemia: a pharmacokinetic and pharmacodynamic investigation.
- Quantitative assessment of Aortic sclerosis using ultrasonic backscatter.
- The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon.
- Determination of l-arginine and NG, NG - and NG, NG' -dimethyl-L-arginine in plasma by liquid chromatography as AccQ-Fluor fluorescent derivatives.
- Effect of perindopril on platelet nitric oxide resistance in patients with Chronic heart failure secondary to ischemic left ventricular dysfunction.
- Seasonal variation in AF-related admissions to a coronary care unit in a "hot" climate: fact or fiction?
- A new solution for an old problem? Effects of a nurse-led, multidisciplinary, home-based intervention on readmission and mortality in patients with Chronic atrial fibr...
- The role of endothelin in mediating ischemia/hypoxia-induced atrial natriuretic peptide release.
- Tolerance induction during therapy with long-acting nitrates: how extensive is the "collateral damage"?
- Usefulness of tachycardic-stress perfusion imaging to predict coronary Artery disease in high-risk patients with chronic renal failure.
- Survival after myocardial reVascularization for ischemic cardiomyopathy: a prospective ten-year follow-up study.
- Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon.
- Mibefradil: "Has the baby been thrown out with the bath water?".
- Amelioration of nitrate tolerance: matching strategies with mechanisms.
- Myocardial uptake and biochemical and hemodynamic effects of ACE inhibitors in humans.
- Association of Aortic stenosis with platelet hyperaggregability and impaired responsiveness to nitric oxide.
- Home-based intervention in congestive heart failure: long-term implications on readmission and survival.
- Resolution of ST-segment elevation following intraVenous administration of nitroglycerin and verapamil.
- Exploiting cGMP-based therapies for the prevention of left ventricular hypertrophy: NO* and beyond.
- ST elevation secondary to microVascular dysfunction.
- Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial.
- Clinical trials update from the European Society of Cardiology congress in Munich, 2008: TIME-CHF, CARESS-in-AMI, TRITON-TIMI 38, EUROPA, AF-CHF, and ADVANCE.
- Determinants of in vitro nitroglycerin tolerance induction and reversal: influence of dose regimen, nitrate-free period, and sulfhydryl supplementation.
- Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
- Inhibition of long-chain fatty acid metabolism does not affect platelet aggregation responses.
- Temporal trends in major angioplasty complications: technical issues and the case for on-site coronary surgery.
- Sotalol-induced torsade de pointes: management with magnesium infusion.
- Postextrasystolic potentiation in patients with ischaemic heart Disease: influence of inotropic agents.
- The coronary slow flow phenomenon--a new coronary microVascular disorder.
- Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY.
- Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival study.
- Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexiline.
- Nitrate therapy is an alternative to furosemide/morphine therapy in the management of Acute cardiogenic pulmonary edema.
- Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation.
- Silent ischemia after uncomplicated myocardial infarction: lack of incremental clinical significance.
- Surgery for Carotid artery stenosis following neck irradiation.
- Platelet nitrate responsiveness in fasting and postprandial type 2 diabetes.
- Increase in reactivity of human platelet guanylate cyclase during aggregation potentiates the disaggregating capacity of sodium nitroprusside.
- Elimination, but not accumulation, of metoprolol by rat isolated perfused heart is selectively impaired by hypoxia.
- Determinants of insulin responsiveness in young women: Impact of polycystic ovarian Syndrome, nitric oxide, and vitamin D.
- Multi-centre experience on the use of perhexiline in Chronic heart failure and refractory angina: old drug, new hope.
- Utility of a weight-based heparin nomogram for patients with Acute coronary syndromes.
- Clinical Trials Update Esc Congress 2011.
- Ramipril retards development of Aortic valve stenosis in a rabbit model: mechanistic considerations.
- Specialist nurse management programmes: economic benefits in the management of heart failure.
- Thiol-containing agents in the management of unstable angina pectoris and Acute myocardial infarction.
- S-nitrosothiol modulation of tolerance to glyceryl trinitrate in bovine isolated coronary Artery.
- Role of nitrates in unstable angina pectoris.
- Effects of glyceryl trinitrate tolerance on vascular responsiveness to constrictor agents in bovine isolated coronary Artery.
- The endogenous NOS inhibitor asymmetric dimethylarginine (ADMA) predicts LV mass independent of afterload.
- Native and oxidized low density lipoproteins enhance platelet aggregation in whole blood.
- Efficacy and safety of high-dose lisinopril in Chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATL...
- Regional differences in the characteristics and treatment of patients participating in an international heart failure trial. The Assessment of Treatment with Lisinopri...
- Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in Chronic heart failure: a cost-effectiveness analysis based on the Assessment of T...
- Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with Chronic heart failure: results from the ATLAS trial. The Assessment of Treatment ...
- Myocardial salvage with streptokinase combined with nitroglycerine and verapamil in Acute myocardial infarction.
- Verapamil hepatotoxicity: a hypersensitivity reaction.
- Attenuation of coronary vascular resistance by selective alpha 1-adrenergic blockade in patients with coronary Artery disease.
- The WHICH? trial: rationale and design of a pragmatic randomized, multicentre comparison of home- vs. clinic-based management of Chronic heart failure patients.
- Verapamil in unstable angina pectoris: failure to demonstrate a relationship between efficacy and plasma levels.
- Nitrate tolerance induced by nicorandil or nitroglycerin is associated with minimal loss of nicorandil vasodilator activity.
- Relationship between systemic and coronary Vascular responses to digoxin and concurrent drug therapy with verapamil/beta-adrenoceptor antagonists in humans.
- Perhexiline maleate treatment for severe angina pectoris--correlations with pharmacokinetics.
- Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary Artery disease.
- Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris.
- Short-term myocardial uptake of lidocaine and mexiletine in patients with ischemic heart Disease.
- Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade.
- Silent myocardial ischaemia is uncommon after uncomplicated Acute myocardial infarction.
- Metabolic manipulation in ischaemic heart Disease, a novel approach to treatment.
- Salvage of Acutely ischaemic myocardium: individual quantification.
- Multiple agonist induction of aggregation: an approach to examine anti-aggregating effects in vitro.
- Tolerance induction by transdermal glyceryl trinitrate in rats.
- Peripherally inserted central catheters revisited.
Schools
Temple University School Of Medicine
Episcopal Hospital
Temple University Hosps
Ohio State University Hosps
Brandeis U
Procedures Preformed
- Carotid Endarterectomy (CEA) or Excision of Infected Graft
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- EndoVenous Laser Treatment
- Non-Coronary Angioplasty, Atherectomy, and Stenting
- View All
Conditions Treated
- Abdominal Aortic Aneurysm (AAA)
- Acute Deep Vein Thrombosis (DVT)
- Aortic Aneurysm
- Brachial Plexus Palsy
- View All
Doctors Specialties
- General Surgery
- Phlebology
- Vascular Surgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
Ohio State University Hospital -
Temple University Hospital -
Temple University School of Medicine
Drug Facts
| NPI NUMBER | 1497729214 | |
| NPPES Provider LastName | HOROWITZ | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 347613436 | |
| NPPES Provider State | FL | |
| Specialty Description | General Surgery | |
| Total Claim Count | 274.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 63.0 | |
| Percent Opioid Claims | 22.99 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497729214 |
| Last Name Of The Provider | HOROWITZ |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
Dr. Jason A. Boardman, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Jorge L. Florin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joseph M. Armotrading II, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Charles S. Thompson, MD |
|
|
Dr. David J. Wright, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Sustarsic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher J. Johnson, DO |
|
|
Dr. Carlos Trillo, MD
This Doctor is OpenDoctor Recommended.
|